China Pharma Holdings (CPHI) EPS (Diluted) Growth (3y) (2014 - 2026)
China Pharma Holdings (CPHI) EPS (Diluted) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | 82.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.85% |
| Dec 31, 2025 | 70.44% |
| Sep 30, 2025 | 71.97% |
| Jun 30, 2025 | 74.86% |
| Mar 31, 2025 | 72.68% |
| Dec 31, 2024 | -7.68% |
| Sep 30, 2024 | -10.58% |
| Jun 30, 2024 | -20.36% |
| Mar 31, 2024 | -7.60% |
| Dec 31, 2023 | -0.63% |
| Sep 30, 2023 | 8.34% |
| Jun 30, 2023 | -261.99% |
| Mar 31, 2023 | 10.36% |
| Dec 31, 2022 | 59.30% |
| Sep 30, 2022 | -4.10% |
| Jun 30, 2022 | -1.96% |
| Mar 31, 2022 | -35.08% |
| Dec 31, 2021 | 49.45% |
| Sep 30, 2021 | 23.64% |
| Jun 30, 2021 | 6.47% |